Cytokine Levels and Symptoms Among Women with Irritable Bowel Syndrome: Considering the Role of Hormonal Contraceptive Use.
Kendra J KampClaire HanRobert J ShulmanKevin C CainPamela BarneyMark R OppLin ChangRobert L BurrMargaret M HeitkemperPublished in: Biological research for nursing (2020)
These results suggest that hormonal contraceptive use might reduce IL-1β and TNF-α cytokine levels in women with IBS. The impact of hormonal contraceptive use on innate immune activation among women with IBS requires further research.